physostigmine has been researched along with Remission, Spontaneous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruun, R; Shapiro, AK; Shapiro, E; Sweet, RD | 1 |
| Davis, JM; el-Yousef, K; Janowsky, DS; Sekerke, HJ | 1 |
2 trial(s) available for physostigmine and Remission, Spontaneous
| Article | Year |
|---|---|
Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine.
Topics: Adolescent; Adult; Benztropine; Brain; Brain Chemistry; Catecholamines; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Methyltyrosines; Physostigmine; Placebos; Receptors, Drug; Remission, Spontaneous; Scopolamine; Tetrabenazine; Tourette Syndrome | 1974 |
Parasympathetic suppression of manic symptoms by physostigmine.
Topics: Acetylcholine; Adult; Affect; Bipolar Disorder; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Injections, Intravenous; Male; Neostigmine; Norepinephrine; Parasympathetic Nervous System; Physostigmine; Placebos; Remission, Spontaneous; Schizophrenia | 1973 |